It has been demonstrated that DLBCL recurring SNVs disrupt the binding of transcription repressors BLIMP1 or NR3C1 and thereby lead to the upregulation of SS-to-SE associated genes CXCR4 and BCL664. The gene discussed is CXCR4; the disease is diffuse large B-cell lymphoma.